Correction: L-Arginine in diabetes: clinical and preclinical evidence

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Correction: L-Arginine in diabetes: clinical and preclinical evidence ; volume:22 ; number:1 ; day:18 ; month:5 ; year:2023 ; pages:1 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (18.5.2023), 1, 12.2023

Creator: Forzano, Imma
Avvisato, Roberta
Varzideh, Fahimeh
Jankauskas, Stanislovas S.
Cioppa, Angelo
Mone, Pasquale
Salemme, Luigi
Kansakar, Urna
Tesorio, Tullio
Trimarco, Valentina
Santulli, Gaetano

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12933-023-01852-1

URN: urn:nbn:de:101:1-2023090911521935271173

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Forzano, Imma
Avvisato, Roberta
Varzideh, Fahimeh
Jankauskas, Stanislovas S.
Cioppa, Angelo
Mone, Pasquale
Salemme, Luigi
Kansakar, Urna
Tesorio, Tullio
Trimarco, Valentina
Santulli, Gaetano
SpringerLink (Online service)

Other Objects (12)

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Hochschulschrift

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction: L-Arginine in diabetes: clinical and preclinical evidence

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

L-Arginine in diabetes: clinical and preclinical evidence

Correction: A novel strategy for L-arginine production in engineered Escherichia coli

Transport of L-Arginine Related Cardiovascular Risk Markers

L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy

Controlled drug delivery of L-Arginine from a polymer matrix

Cleansing effect of acidic L-arginine on human oral biofilm

Purification and characterization of L-arginine deiminase from Penicillium chrysogenum

Controlled drug delivery of L-Arginine from a polymer matrix

L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis

Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

A novel strategy for l-arginine production in engineered Escherichia coli

Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production

Related objects

Reset password